CellaVision AB (publ)
Stockholm Stock Exchange:CEVI.ST
Sector
Location
Market Cap
USD 430.32 M
Share Price
USD 18.04
Avg Daily Volume
17,175
Change (1 day)
-1.23%
Change (1 year)
-21.98%
Change (YTD)
-8.14%
CellaVision AB (publ) Operating Cash Flow for the year ending December 31, 2024: USD 17.86 M
CellaVision AB (publ) Operating Cash Flow is USD 17.86 M for the year ending December 31, 2024, a -7.89% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
CellaVision AB (publ) Operating Cash Flow for the year ending December 31, 2023 was USD 19.39 M, a 47.88% change year over year.
-
CellaVision AB (publ) Operating Cash Flow for the year ending December 31, 2022 was USD 13.11 M, a -25.44% change year over year.
-
CellaVision AB (publ) Operating Cash Flow for the year ending December 31, 2021 was USD 17.58 M, a 104.00% change year over year.
-
CellaVision AB (publ) Operating Cash Flow for the year ending December 31, 2020 was USD 8.62 M, a -35.70% change year over year.
StockViz
Competitors
Vitrolife AB (publ)
USD 14.67
VITR.ST
-0.30
-2.00%
Mycronic AB (publ)
USD 22.12
MYCR.ST
+0.08
0.37%
Sectra AB (publ)
USD 37.83
SECT-B.ST
+0.62
1.66%
BioGaia AB (publ)
USD 9.93
BIOG-B.ST
-0.70
-6.57%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|